American Cancer Society

July 15, 2015

Drug signaling networks

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.

By Leigh MacMillan
xray of lung
May 28, 2015

VU study to explore Accountable Care Organizations’ impact on cancer screenings

As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects.

By VUMC News and Communications
July 17, 2013

Probing roles of a cell death protein

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.

By Leigh MacMillan
May 2, 2013

National cancer prevention study enrolls 168 at Vanderbilt

By VUMC News and Communications
March 28, 2013

VU to serve as host site for ACS cancer prevention study

Most cancers are sporadic, which means that physicians don’t have enough clues to determine what caused an individual’s disease.

By VUMC News and Communications
February 6, 2013

‘Champions’ wanted for nationwide cancer prevention study

By VUMC News and Communications
October 25, 2012

Bid protein guards blood cells against stress

A protein normally known to promote cell death found to encourage survival of blood forming cells.
By VUMC News and Communications
August 16, 2012

African ancestry, stomach bug link

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection.
By VUMC News and Communications
July 26, 2012

On the hunt for bladder cancer factors

A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.
By Leigh MacMillan
June 11, 2012

Vanderbilt identifies genes linked to breast cancer chemo resistance

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
By VUMC News and Communications
April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
By VUMC News and Communications
1 2 3 4